Across this entire round of reviews, the most consistent hidden cost has been dose escalation — the price that quietly climbs as you titrate. Independent Wellness promises it will not. That is a genuinely valuable thing to offer, and it sits on the same page as the most troubling product tier we have found.
The Price Lock Is the Real Feature
Compounded semaglutide injections start at $99 per month and compounded tirzepatide at $199. Each plan states it includes medication delivered monthly, unlimited provider visits, labs included, and — the unusual part — “Your Monthly Price Never Increases”.
This addresses the single most common cost surprise in the category. Semaglutide is titrated from 0.25 mg toward a maintenance dose up to 2.4 mg, and compounded pricing almost always rises along that path — which is why so many competitors quote “as low as” or “starting at” figures that describe month one and nothing after.
A locked rate turns an entry price into an annual budget. At $99 a month, a year is $1,188 — knowable in advance, which is more than we can say for most of the field. TRAVA quotes $88.65 “as low as” with no published ceiling; Curex goes from $49 to $199 after month one.
Labs included at that price is also notable. We reviewed a practice charging a $450 minimum lab spend on top of a $299 consultation, and another that states labs are “not included and not waived”. Unlimited provider visits at no extra charge is similarly generous on paper.
Care is delivered by a named board-certified nurse practitioner, and no payment is required until you are approved — so an unsuccessful application costs nothing. Both molecules are named, and the site states plainly that compounded GLP-1 medications are not FDA-approved.
A Tier for People Who Do Not Qualify
A microdosing plan at $199 a month is described as ideal for patients who have reached their goal and want to maintain, who want to lose 10–15 pounds, or who “do not qualify for full-dose GLP-1 programs based on BMI”.
That third bullet is the most explicit statement of its kind we have found anywhere. It markets a sub-therapeutic dose specifically to the people who fail the eligibility criteria — and the criteria exist because that is the population in which these drugs were trialled and found to be safe and effective.
Two problems compound here. The first is the one we have flagged repeatedly: there is no established microdosing protocol for semaglutide or tirzepatide. Both were studied at defined doses with defined escalation schedules, and a dose below that range has not been tested for weight loss. It is an untested dose, not a gentler version of a tested one.
The second is new. Elsewhere — at Invigor Medical, Belle, Measured — microdosing is sold as a gentler option to people who would otherwise qualify for the full dose. Here it is positioned as a route around the BMI gate. Someone told they are not eligible is offered a product tier instead of an explanation, and the framing invites them to read ineligibility as a pricing question rather than a clinical finding.
The “want to lose 10–15 pounds” bullet points the same way. That is well below the population these medications are indicated for — broadly a BMI of 30, or 27 with a weight-related condition. Our GLP-1 eligibility guide sets out where those thresholds come from and why they are not arbitrary.
To be fair to the practice, a prescriber still assesses every patient, and maintenance dosing after reaching a goal weight is a legitimate clinical use. It is the middle justification — not qualifying — that we would not want anyone to act on.
The Drops Cost More Than the Injections
Oral formulations are priced at $249 for sublingual semaglutide and $379 for sublingual tirzepatide — against $99 and $199 for the injections.
So the needle-free option costs roughly two and a half times the injectable one. And the route it uses has the weakest published evidence of anything on the menu: pharmacokinetic work puts oral semaglutide bioavailability at roughly 0.02% to 0.9% of a subcutaneous dose, against about 89% for the injection.
The FDA-approved oral semaglutide tablet overcomes that with an absorption enhancer, a strict fasting protocol and roughly ten times the milligram dose. A compounded sublingual drop replicates none of that and has no published pharmacokinetics of its own — the same problem we set out at Wisp and Shed.
Paying a large premium for the least-established route is the wrong way round. If needles are genuinely the obstacle, the approved oral tablet has trial data behind it and is worth pricing first.
Is It the Lowest Price Online?
The site claims “The lowest prices online!” and “America’s most affordable clinician-supervised program”. Those are checkable, so we checked.
On medication price alone, no. Ozari Health publishes $86 for compounded semaglutide and TRAVA $88.65, both below $99.
On the bundle, the claim is much stronger. Neither of those includes labs or unlimited provider visits, and neither locks the price against dose escalation. Add the cost of independent bloodwork to a cheaper competitor and $99 all-in is genuinely competitive — arguably the best value in the category once you account for what is included.
The honest verdict is that the superlative is overstated as written and defensible as intended. We would rather see the bundle argued than the superlative asserted, because the bundle is the actually impressive part.
Provider Facts
| Medications offered | Compounded semaglutide and tirzepatide injections, sublingual oral semaglutide and tirzepatide drops, and a microdosing tier |
|---|---|
| Brand-name or compounded | Compounded, stated plainly as not FDA-approved; partners described as FDA-compliant compounding pharmacies meeting state pharmacy regulations |
| Consultation process | Telehealth visit with a named board-certified nurse practitioner; no payment required until approved |
| Eligibility | No BMI threshold published; a microdosing tier is offered to patients who do not qualify for full-dose programmes on BMI |
| Provider involvement | A single named board-certified nurse practitioner, with unlimited provider visits included in every plan |
| Lab requirements | Included in the plan price; lab review described as part of provider-supervised care when needed |
| Pharmacy fulfillment | Licensed US compounding pharmacies; not individually named |
| Shipping frequency | Medication delivered monthly; timings not published |
| Support services | Unlimited provider visits, refill coordination, maintenance planning and lifestyle guidance |
| Membership fees | None separate - plan pricing is the cost |
| Medication fees | Semaglutide injection from $99/month, tirzepatide injection from $199, oral semaglutide $249, oral tirzepatide $379, microdosing $199 - each stated to never increase |
| Cancellation policy | Not published |
| Refund policy | Not published |
| Insurance | Not published |
| HSA/FSA | Not published |
| Availability | Stated as multiple approved states including New York; no list published |
Pros and Cons
Pros
- Price locked against dose escalation — the rarest promise in this category
- Labs included in the plan price
- Unlimited provider visits at no extra charge
- $99 a month makes a year’s cost knowable in advance at $1,188
- Both molecules named, with every tier priced openly
- States plainly that compounded GLP-1s are not FDA-approved
- A named, board-certified nurse practitioner; no payment until approved
Cons
- Microdosing marketed to people who do not meet BMI criteria
- Also pitched at those wanting to lose 10–15 lb, far below the indication
- No established microdosing protocol exists for either molecule
- Oral drops cost ~2.5x the injections for the weakest-absorption route
- “Lowest prices online” is not accurate on medication price alone
- “FDA-compliant” is not a designation the FDA confers
- No state list, cancellation or refund policy published
Who It May Be Best For
A strong fit if you meet the standard criteria, want compounded semaglutide, and value knowing your cost will not move. At $99 with labs and visits included, the injectable plan is one of the better-value offers we have found.
Get the price lock in writing. It is the main reason to choose this service, so confirm it applies at every dose and for the life of the plan, and ask what happens if you switch molecules.
Take the injection, not the drops. The oral options cost far more for the route with the least evidence behind it.
If you are told you do not qualify on BMI, treat that as the answer — not as a prompt to buy the microdose tier. Ask instead what the clinical reasoning is and what a sub-therapeutic dose is expected to achieve, and weigh the fact that nobody has studied it.
Alternatives
Ozari Health is cheaper on medication but without labs or a price lock. NexLife publishes third-party testing. PRIME Medical Group bundles bloodwork into a $149 visit. Our cheapest GLP-1 programs page ranks the value end.
Limitations of This Review
Based on Independent Wellness’s own published materials at independent-wellness.com, checked on 6 September 2026, across its pricing and telehealth pages. Annual totals are our arithmetic from the published monthly rates. The price-lock promise is the company’s own claim and we have not tested it in practice, which is why we suggest getting it in writing. Our comparison against competitors’ prices reflects figures published on their own sites as reviewed here. Bioavailability figures for oral and subcutaneous semaglutide come from the published pharmacokinetic literature and describe the route rather than this provider’s formulation. Statements about microdosing reflect published trial regimens, not claims by Independent Wellness. Nothing here is medical advice.
Frequently Asked Questions
Does the price really never increase?
That is what the plans state, and it is unusual — most compounded pricing rises as your dose escalates. It is the main reason to consider this service, so get the guarantee in writing and confirm it holds at every dose.
Should I take the microdosing plan if I do not qualify?
We would not. Not qualifying on BMI is a clinical finding, and no microdosing protocol has been established for semaglutide or tirzepatide — a dose below the studied range has not been tested for weight loss. Maintenance dosing after reaching a goal is a different and legitimate use.
Are the oral drops worth $249?
They cost roughly 2.5 times the $99 injection for the route with the weakest published absorption — oral semaglutide bioavailability is around 0.02% to 0.9% of a subcutaneous dose. If needles are the obstacle, the FDA-approved oral tablet has actual trial data.
Is $99 really the lowest online?
Not on medication alone — Ozari Health publishes $86 and TRAVA $88.65. But neither includes labs, unlimited visits or a locked price, so on the full bundle $99 is genuinely competitive.
Verdict
3.0 / 5 — semaglutide from $99/month with labs, price locked
The injectable plan is one of the strongest value propositions we have found — labs, unlimited visits and a rate that cannot climb. It shares a page with a microdosing tier sold to people who do not meet the criteria, and oral drops priced far above the injections for far less evidence.
The point worth carrying beyond this provider: being told you do not qualify is clinical information, not a negotiating position. When a service responds to ineligibility by offering a cheaper, smaller, untested version of the same drug, the thing being solved is the sale rather than the patient.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Independent Wellness's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: September 6, 2026